Making, Cloning, and the Expression of Human Insulin Genes in Bacteria: The Path to Humulin
Overview
Authors
Affiliations
In the mid- to late 1970s, recombinant deoxyribonucleic acid methods for cloning and expressing genes in E. coli were under intense development. The important question had become: Can humans design and chemically synthesize novel genes that function in bacteria? This question was answered in 1978 and in 1979 with the successful expression in E. coli of 2 mammalian hormones, first somatostatin and then human insulin. The successful production of human insulin in bacteria provided, for the first time, a practical, scalable source of human insulin and resulted in the approval, in 1982, of human insulin for the treatment of diabetics. In this short review, I give my personal view of how the making, cloning, and expressing of human insulin genes was accomplished by a team of scientists led by Keiichi Itakura, Herbert W. Boyer, and myself.
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery.
Tenchov R, Hughes K, Ganesan M, Iyer K, Ralhan K, Lotti Diaz L ACS Nano. 2025; 19(4):4011-4038.
PMID: 39823199 PMC: 11803921. DOI: 10.1021/acsnano.4c09566.
Frederick G Banting (1891-1941): A Pioneer in Diabetes Treatment.
Sharma Y, Kannan A, Lee J, Coffman F, Mittal R Cureus. 2024; 16(11):e73806.
PMID: 39691108 PMC: 11650121. DOI: 10.7759/cureus.73806.
Rahban M, Ahmad F, Piatyszek M, Haertle T, Saso L, Saboury A RSC Adv. 2023; 13(51):35947-35963.
PMID: 38090079 PMC: 10711991. DOI: 10.1039/d3ra06476j.
Nkonge K, Nkonge D, Nkonge T Diabetes Ther. 2023; 14(11):1801-1831.
PMID: 37736787 PMC: 10570256. DOI: 10.1007/s13300-023-01468-4.
Amplifying gene expression with RNA-targeted therapeutics.
Khorkova O, Stahl J, Joji A, Volmar C, Wahlestedt C Nat Rev Drug Discov. 2023; 22(7):539-561.
PMID: 37253858 PMC: 10227815. DOI: 10.1038/s41573-023-00704-7.